More Big Pharma Companies Cough Up Big Dollars in DOJ Settlements


The parade of major drug companies coughing up nine-digit or ten-digit dollar amounts in settlements with the U.S. government is continuing.

GlaxoSmithKline recently broke a record by agreeing to pay the federal government $3 billion to settle an illegal pharmaceutical marketing case. This surpasses the previous record of $2.3 billion paid by Pfizer in 2009 over the marketing of its Bextra painkiller and other drugs. The same year, Eli Lilly & Co. paid $1.4 billion in a settlement concerning sales of its Zyprexa anti-psychotic medicine. In late November, Merck & Co. agreed to pay $950 million and plead guilty to a criminal misdemeanor charge to resolve allegations that it illegally promoted its former painkiller Vioxx and deceived the government about the drug’s safety.

Please see full article below for more information.

LOADING PDF: If there are any problems, click here to download the file.